Literature DB >> 27504333

Association of Systemic Lupus Erythematosus and Beta Thalassaemia Trait- A Case Report.

Bimal Kumar Agrawal1, Saurabh Marwaha2, Mini Bhatnagar3, Shabir A Parry4, Usha Agrawal5.   

Abstract

Systemic Lupus Erythematosus (SLE) is a multisystem chronic inflammatory disease of autoimmune aetiology. It has a predilection for female gender and presence of photosensitive rash over the sun exposed area gives a clue to the diagnosis. Diagnosis in a male patient with atypical manifestations is unusual and difficult. A 25-year-old male presented with fever, fatigue, vomiting, abdominal pain and loss of weight. He had sustained injury on his right arm following which he developed abscess at the trauma site and severe anaemia. Further evaluation revealed pancytopenia and peritonitis. Though peritonitis is rare in SLE, it was considered in the differential diagnosis after ruling out bacterial and tubercular peritonitis. Positive anti-dsDNA and antiSm antibodies confirmed the diagnosis. While evaluating for microcytic anaemia it was found that iron studies were normal and A2 fraction was raised in haemoglobin electrophoresis. The symptoms and laboratory parameters improved remarkably with steroid therapy. Beta thalassaemia trait is rare in patients with SLE, but when they co-exist the manifestations can be severe. High degree of suspicion is required to diagnose SLE in male patients in absence of typical photosensitive rash. Beta thalassaemia trait often does not require any treatment except genetic counseling. However empirical treatment with iron should be avoided.

Entities:  

Keywords:  Lupus peritonitis; Microcytic anaemia; Pancytopenia

Year:  2016        PMID: 27504333      PMCID: PMC4963693          DOI: 10.7860/JCDR/2016/19803.7933

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  9 in total

1.  Beta-thalassaemic trait and systemic lupus erythematosus.

Authors:  G Castellino; M Govoni; F Trotta
Journal:  Clin Exp Rheumatol       Date:  2004 May-Jun       Impact factor: 4.473

2.  Beta thalassaemic trait and systemic lupus erythematosus.

Authors:  G Castellino; M Govoni; M Padovan; N Rizzo; F Trotta
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

3.  Gastrointestinal symptom due to lupus peritonitis: a rare form of onset of SLE.

Authors:  Rongquan Liu; Li Zhang; Sujun Gao; Lei Chen; Lu Wang; Zhen Zhu; Wei Lu; Haihang Zhu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Emerging symptoms of systemic lupus erythematosus triggered by knee injury.

Authors:  S Imashuku; N Kudo; S Kaneda
Journal:  Lupus       Date:  2010-01-11       Impact factor: 2.911

Review 5.  Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment.

Authors:  Xin-Ping Tian; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

Review 6.  β-Thalassemia trait association with autoimmune diseases: β-globin locus proximity to the immunity genes or role of hemorphins?

Authors:  Meric A Altinoz; Gunduz Gedikoglu; Gunnur Deniz
Journal:  Immunopharmacol Immunotoxicol       Date:  2011-07-28       Impact factor: 2.730

7.  Ascites in systemic lupus erythematosus.

Authors:  A Mier; W Weir
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

8.  Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse.

Authors:  K Anam; M Amare; S Naik; K A Szabo; T A Davis
Journal:  Lupus       Date:  2009-04       Impact factor: 2.911

9.  Successful treatment of massive ascites with intraperitoneal administration of a steroid in a case of systemic lupus erythematosus.

Authors:  Q G Zhou; X B Yang; F F Hou; X Zhang
Journal:  Lupus       Date:  2009-07       Impact factor: 2.911

  9 in total
  1 in total

1.  Prevalence and characteristics of inflammatory rheumatic diseases in patients with thalassemia.

Authors:  Pokpong Piriyakhuntorn; Adisak Tantiworawit; Nuntana Kasitanon; Worawit Louthrenoo
Journal:  Ann Hematol       Date:  2022-05-23       Impact factor: 4.030

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.